Chalmers Ventures AB — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Drug development company specializing in automated, standardized production of At-211 radiopharmaceuticals for targeted alpha therapy.
Milton Lönnroth(Founder)in
Co-investorsFSG
Seaqure Labs develops mycelium-based protein for animal feed, designed as a sustainable alternative to soy and conventional proteins.
BiotechCircular EconomyFoodTech
Co-investorsEIT Food Accelerator Network
Swedish Algae Factory cultivates diatoms and extracts their silica shells, marketed as Algica®, a material used in high-end oceanic beauty care products and applications such as solar panel efficiency enhancement.
Circular EconomyCleantechNew MaterialsKungshamn, SE
Co-investorsAqua SparkMindshift CapitalPowerhouse
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.